Skip to main content
UniHealth

Doctor search

Eyad Almasri, MD

Critical Care (Intensivists) · Fresno

NPI 1992840490

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
5
Since medical school
30 years
Graduated 1996

Offices

5 locations · Central California Faculty Medical Group Inc · Fresno Community Hospital and Medical Center

Looking this up.

Hospitals listed: Clovis Community Medical Center · Community Regional Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Almasri’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A111780 · Current

Licensed to practise in California · since 2010 · expires 2027-05-31 · University of Damascus Faculty of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Internal Medicine - Critical Care Medicine
  • American Board of Internal Medicine - Pulmonary Disease
  • American Board of Internal Medicine - Sleep Medicine

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend it
    Overall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
  • Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend it
    Overall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
See every measure and the patient survey for Clovis Community Medical Center

Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Clovis Community Medical Center
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.7 (12.1 to 17.7) · 421 casesWorseJan 2024 – Dec 2024
Clostridium Difficile (C.Diff)Infections0.692BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.97 (0.04 to 1.89) · 1,840 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.16 (0.86 to 1.45)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths217.06 (167.45 to 266.67) · 84 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.4 · 69 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths9.1 · 165 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths13.4 · 161 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths14 · 507 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths17.6 · 798 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 336 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.1 · 3,771 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.19 (0 to 0.39) · 8,649 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.08 to 0.46) · 9,146 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.46 (1.47 to 5.45) · 1,654 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2.19 (0.61 to 3.78) · 387 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.18 (0.7 to 3.66) · 1,578 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths13.47 (7.08 to 19.87) · 374 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.99 (1.37 to 8.61) · 379 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.58 (0.13 to 3.04) · 405 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.8 (0.23 to 1.38) · 8,198 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.2 · 90 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.651No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.922No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.449No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.509No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.3 · 210 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits23 · 702 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-1.5 · 152 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits58.4 · 556 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits18 · 769 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17.8 · 802 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.5 (4 to 7.4) · 421 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.2 · 91 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 93 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 200 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.8 to 15.6) · 2,398 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.6 to 1.1) · 720 casesNo differentJan 2024 – Dec 2024

What patients said (441 patients answered, 26% of those asked)

Patient survey stars by topic at Clovis Community Medical Center
Cleanliness4
Nurse communication3
Doctor communication2
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Clovis Community Medical Center
Room was "always" clean80%
Nurses "always" communicated well75%
Doctors "always" communicated well75%
Staff "always" explained61%
Yes, staff "did" give patients this information87%
Yes, staff "did" give patients information about help after discharge85%
Doctors "always" explained things so they could understand69%
Doctors "always" listened carefully73%
Doctors "always" treated them with courtesy and respect84%
Patients who gave a rating of "9" or "10" (high)72%
Staff "always" explained new medications74%
Nurses "always" explained things so they could understand71%
Nurses "always" listened carefully71%
Nurses "always" treated them with courtesy and respect83%
"Always" quiet at night52%
"YES", patients would definitely recommend the hospital80%
Staff "always" explained possible side effects48%
Yes, staff "did" give patients information about possible symptoms88%
See every measure and the patient survey for Community Regional Medical Center

Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Community Regional Medical Center
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths211.21 (174.88 to 247.54) · 239 casesWorseJul 2022 – Jun 2024
Clostridium Difficile (C.Diff)Infections0.705BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.13 (0.29 to 1.96) · 2,304 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.09 (0.87 to 1.3)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths3.2 · 187 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 116 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.7 · 187 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.6 · 445 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.2 · 399 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 582 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.2 · 3,744 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.31 (0.12 to 0.5) · 11,052 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.1 to 0.45) · 11,566 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.33 (1.64 to 5.01) · 3,139 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.08 (0 to 2.3) · 1,423 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.7 (0.52 to 2.88) · 3,084 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths11.85 (8.11 to 15.6) · 1,481 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.4 (3.81 to 8.98) · 1,404 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.35 (0.95 to 3.76) · 760 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.64 (0.16 to 1.11) · 10,254 casesNo differentJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.817No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections1.031No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.837No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.81No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.853No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.8 · 258 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22 · 689 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits37.4 · 202 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits35.2 · 543 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits39.2 · 434 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19.3 · 552 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.4 (3.6 to 7.9) · 169 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits11.4 (8.3 to 15.4) · 169 casesNo differentJan 2024 – Dec 2024
Rate of readmission for CABGUnplanned return visits12.4 · 189 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits21.6 · 248 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits11.9 (9.5 to 14.9) · 2,590 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.2) · 310 casesNo differentJan 2024 – Dec 2024

What patients said (421 patients answered, 26% of those asked)

Patient survey stars by topic at Community Regional Medical Center
Cleanliness4
Nurse communication2
Doctor communication3
Communication about medicines2
Discharge information4
Overall hospital rating3
Quietness1
Recommend hospital3
Share of patients giving the best answer at Community Regional Medical Center
Room was "always" clean74%
Nurses "always" communicated well74%
Doctors "always" communicated well77%
Staff "always" explained55%
Yes, staff "did" give patients this information87%
Yes, staff "did" give patients information about help after discharge85%
Doctors "always" explained things so they could understand71%
Doctors "always" listened carefully76%
Doctors "always" treated them with courtesy and respect83%
Patients who gave a rating of "9" or "10" (high)66%
Staff "always" explained new medications69%
Nurses "always" explained things so they could understand70%
Nurses "always" listened carefully70%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night43%
"YES", patients would definitely recommend the hospital70%
Staff "always" explained possible side effects41%
Yes, staff "did" give patients information about possible symptoms88%

Original Medicare doctor bills

$57,223

Medicare paid this office $57,223 for 293 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Critical care, first 30-74 minutes50$19,783$165
Short return visit (20+ min)112$7,762$60
New patient visit (45+ min)52$5,749$111
Sleep study in sleep lab (6 years or older)11$5,573$507
Return visit (30+ min)24$2,267$94
See all 13 services
Every Original Medicare service billed
Critical care, first 30-74 minutes50$19,783$165
Short return visit (20+ min)112$7,762$60
New patient visit (45+ min)52$5,749$111
Sleep study in sleep lab (6 years or older)11$5,573$507
Return visit (30+ min)24$2,267$94
Test to examine how well the lungs exchange gases28$1,340$48
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes11$1,024$93
Test to determine lung volumes using sensors20$942$47
Test to measure expiratory airflow and volume changes before and after medication administration25$817$33
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation12$790$66
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's11$144$13
Test to measure expiratory airflow and volume changes before and after medication administration12$80$7
Test to examine how well the lungs exchange gases11$62$6

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Insertion of non-tunneled central venous tube for infusion (5 years or older)–13–1613–
Insertion of artery tube for blood sampling or infusion through skin–––13––
Emergent insertion of breathing tube into windpipe using an endoscope11–––––
Irrigation and suction of lung airways to obtain cells using an endoscope11–––––

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

293 Original Medicare patients in 2024. Average age 72 · Under 65 14% · 85 and older 9% · Women 45% · Also on Medicaid 38% · Health risk score 2.24. Above the middle of the specialty; the typical pulmonary disease clinician is at 2.13.

Conditions among them: High blood pressure 75% · Diabetes 51% · Coronary heart disease 49% · Heart failure 40% · Chronic kidney disease 37% · COPD 35% · Atrial fibrillation 29% · Depression 25% · Cancer 15% · Stroke 15% · Dementia 12%.

The office billed $211,547, Medicare allowed $76,716 and paid $57,223; for 580 services of 36 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024293580722.24$211,547$57,223
2023307525712.11$228,890$64,419
2022370631712.04$260,457$71,699
2021391704712.18$267,029$79,762
2020442809702.41$305,581$90,220
20195071,043712.51$380,719$101,589
2018434882702.45$374,114$104,739
2017506863692.43$440,499$121,848
2016433787692.31$281,702$83,416
2015474938702.45$432,543$127,039
2014408875702.26$463,879$127,935
20135011,140712.39$480,262$139,375

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 9 services

Original Medicare services billed in 2023
Critical care, first 30-74 minutes63$24,036$170
Sleep study in sleep lab (6 years or older)16$8,316$520
New patient visit (45+ min)49$6,211$127
Short return visit (20+ min)84$6,092$73
Return visit (30+ min)51$5,451$99
Insertion of non-tunneled central venous tube for infusion (5 years or older)12$871$67
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation11$859$78
Test to measure expiratory airflow and volume changes before and after medication administration14$114$8
Test to examine how well the lungs exchange gases14$98$7

2022: 14 services

Original Medicare services billed in 2022
Critical care, first 30-74 minutes90$30,727$175
Sleep study in sleep lab with continuous airway pressure (6 years or older)17$8,913$524
Short return visit (20+ min)70$5,034$65
New patient visit (45+ min)32$4,164$130
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes33$3,560$108
Return visit (30+ min)33$3,505$100
Sleep study including heart rate, breathing, and sleep time11$1,490$135
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes14$1,308$82
Insertion of non-tunneled central venous tube for infusion (5 years or older)16$1,081$68
Insertion of artery tube for blood sampling or infusion through skin13$462$36
Test to determine lung volumes using sensors30$273$9
Test to measure expiratory airflow and volume changes before and after medication administration30$242$8
Test to examine how well the lungs exchange gases33$223$7
Test to measure expiratory airflow and volume15$106$6

2021: 11 services

Original Medicare services billed in 2021
Critical care, first 30-74 minutes110$43,183$177
Short return visit (20+ min)89$7,276$73
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes38$4,486$109
New patient visit (45+ min)31$4,313$139
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation24$3,704$154
Return visit (30+ min)16$1,715$107
Test for exercise-induced lung stress15$260$17
Test to determine lung volumes using sensors24$240$10
Test to measure expiratory airflow and volume changes before and after medication administration26$222$9
Test to examine how well the lungs exchange gases30$222$7
Test to measure expiratory airflow and volume20$136$7

2020: 14 services

Original Medicare services billed in 2020
Critical care, first 30-74 minutes125$46,714$182
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes61$7,346$115
Short return visit (20+ min)83$4,730$53
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes26$3,413$88
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation20$3,387$169
New patient visit (45+ min)21$2,607$124
Return visit (30+ min)28$2,395$86
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes20$1,574$61
Insertion of non-tunneled central venous tube for infusion (5 years or older)12$931$72
Test to measure expiratory airflow and volume changes before and after medication administration38$412$11
Test to determine lung volumes using sensors37$378$10
Test for exercise-induced lung stress17$324$19
Test to examine how well the lungs exchange gases42$318$8
Test to measure expiratory airflow and volume15$105$7

2019: 16 services

Original Medicare services billed in 2019
Critical care, first 30-74 minutes77$31,285$177
Sleep study in sleep lab (6 years or older)27$13,015$482
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes94$10,823$106
Short return visit (20+ min)109$7,320$57
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes52$6,881$84
New patient visit (45+ min)45$5,892$131
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes39$3,640$59
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation15$2,580$172
Long return visit (40+ min)11$1,311$119
Emergent insertion of breathing tube into windpipe using an endoscope11$1,252$114
Irrigation and suction of lung airways to obtain cells using an endoscope11$1,154$105
Test to measure expiratory airflow and volume changes before and after medication administration76$763$10
Test to examine how well the lungs exchange gases79$552$7
Test to determine lung volumes using gas dilution or washout40$353$9
Test to determine lung volumes using sensors23$232$10
Test to measure expiratory airflow and volume18$124$7

2018: 13 services

Original Medicare services billed in 2018
Critical care, first 30-74 minutes106$45,737$177
Sleep study in sleep lab (6 years or older)23$11,637$506
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes73$8,272$109
Sleep study in sleep lab with continuous airway pressure (6 years or older)15$7,755$517
Short return visit (20+ min)96$5,406$50
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes49$5,123$59
New patient visit (45+ min)28$3,446$123
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation20$3,124$156
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes23$2,699$84
Return visit (30+ min)14$1,326$83
Test to measure expiratory airflow and volume changes before and after medication administration35$352$10
Test to determine lung volumes using gas dilution or washout32$292$9
Test to examine how well the lungs exchange gases36$246$7

2017: 12 services

Original Medicare services billed in 2017
Critical care, first 30-74 minutes127$49,797$171
Sleep study in sleep lab (6 years or older)39$19,856$509
Sleep study in sleep lab with continuous airway pressure (6 years or older)25$13,368$535
Short return visit (20+ min)156$9,488$53
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes67$7,098$106
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation32$4,729$148
New patient visit (45+ min)34$4,239$125
Long return visit (40+ min)15$1,429$95
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes12$1,263$57
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes11$995$83
Return visit (30+ min)11$952$87
Office for the evaluation and management of established patient that may not require presence of healthcare professional19$315$16

2016: 13 services

Original Medicare services billed in 2016
Critical care, first 30-74 minutes92$35,760$179
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes74$8,306$109
Short return visit (20+ min)117$6,857$54
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes40$4,803$84
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes38$3,741$58
New patient visit (45+ min)31$3,717$120
Long return visit (40+ min)22$2,581$117
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation12$2,050$171
Irrigation and suction of lung airways to obtain cells using an endoscope13$1,468$113
Test to determine lung volumes using gas dilution or washout28$283$10
Test to measure expiratory airflow and volume changes before and after medication administration21$225$11
Test to examine how well the lungs exchange gases29$217$7
Test to measure expiratory airflow and volume12$83$7

2015: 13 services

Original Medicare services billed in 2015
Critical care, first 30-74 minutes172$72,087$177
Sleep study in sleep lab (6 years or older)18$9,248$514
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes67$7,645$109
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes49$7,225$84
Return visit (30+ min)79$7,057$81
New patient visit (45+ min)26$3,329$128
Short return visit (20+ min)39$2,476$59
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation13$2,232$172
Irrigation and suction of lung airways to obtain cells using an endoscope16$2,057$121
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes17$1,827$59
Test to measure expiratory airflow and volume changes before and after medication administration22$236$11
Test to determine lung volumes using gas dilution or washout19$182$10
Test to examine how well the lungs exchange gases17$120$7

2014: 11 services

Original Medicare services billed in 2014
Critical care, first 30-74 minutes174$72,301$178
Sleep study in sleep lab (6 years or older)28$14,357$513
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes51$9,056$84
Return visit (30+ min)85$7,934$79
Sleep study in sleep lab with continuous airway pressure (6 years or older)11$6,012$547
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes48$5,315$111
New patient visit (45+ min)16$1,905$119
Irrigation and suction of lung airways to obtain cells using an endoscope18$1,538$85
Test to measure expiratory airflow and volume changes before and after medication administration19$192$10
Test to determine lung volumes using gas dilution or washout13$121$9
Test to examine how well the lungs exchange gases14$97$7

2013: 14 services

Original Medicare services billed in 2013
Critical care, first 30-74 minutes173$71,102$172
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes73$15,503$82
Return visit (30+ min)108$10,734$83
Sleep study in sleep lab (6 years or older)16$8,731$546
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes73$8,556$108
Sleep study in sleep lab with continuous airway pressure (6 years or older)12$6,859$572
New patient visit (45+ min)37$4,858$131
Irrigation and suction of lung airways to obtain cells using an endoscope24$2,226$93
Diagnostic exam of lung airway using an endoscope12$1,413$118
Test to measure expiratory airflow and volume changes before and after medication administration46$493$10
Test to determine lung volumes using gas dilution or washout28$293$10
Test to examine how well the lungs exchange gases28$215$8
Exam of lung airways using an endoscope12$132$11
Test to measure expiratory airflow and volume19$124$7

Medicaid work

$16,492 in 2024

Medicaid paid $16,492 for 316 billed services this clinician did in 2024, up to 27 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Clinic visit/encounter, all-inclusive27$10,279
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes161$4,991
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES54$985
IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES13$117
Short return visit (20+ min)25$82
Return visit (30+ min)36$38
Medicaid work by year
2024316627$16,492
2023538925$31,906
2022572534$25,380
2021477626$39,851
2020587545$58,165
2019204323$20,917
2018297334$15,628
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Clinic visit/encounter, all-inclusive61$21,525
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes255$9,902
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES44$165
EVALUATION OF WHEEZING33$117
Diffusing capacity36$90
Plethysmography for determination of lung volumes and, when performed, airway resistance15$68
Short return visit (20+ min)61$24
Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation13$16
Return visit (30+ min)20$0

2022

Largest Medicaid services in 2022
Clinic visit/encounter, all-inclusive56$16,658
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes360$8,691
Short return visit (20+ min)116$24
Diffusing capacity26$7
EVALUATION OF WHEEZING14$0

2021

Largest Medicaid services in 2021
Clinic visit/encounter, all-inclusive93$27,795
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes274$12,056
EVALUATION OF WHEEZING12$0
Diffusing capacity13$0
Short return visit (20+ min)67$0
Return visit (30+ min)18$0

2020

Largest Medicaid services in 2020
Clinic visit/encounter, all-inclusive142$34,729
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes358$23,243
IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES13$193
Short return visit (20+ min)54$0
Return visit (30+ min)20$0

2019

Largest Medicaid services in 2019
Clinic visit/encounter, all-inclusive59$12,781
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes124$7,156
IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES21$979

2018

Largest Medicaid services in 2018
Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes254$12,107
Clinic visit/encounter, all-inclusive12$2,625
IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES31$896

Drugs they prescribed that Part D paid

$82,999

Pharmacies billed $82,999 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 245) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.

83 generic and 162 brand-name prescriptions · $82,999 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Trelegy Ellipta66$43,596$661
Breo Ellipta40$15,973$399
Qvar Redihaler11$3,093$281
Fluticasone-Salmeterol13$1,736$134
Fluticasone Propionate12$369$31
See all 6 drugs
Every Part D drug this clinician prescribed
Trelegy Ellipta66$43,596$661
Breo Ellipta40$15,973$399
Qvar Redihaler11$3,093$281
Fluticasone-Salmeterol13$1,736$134
Fluticasone Propionate12$369$31
Albuterol Sulfate Hfa12$302$25

Year by year

Part D prescribing by year
2024245740% (0)66%$82,999
202320254None69%$78,267
2022186470% (0)78%$75,269
2021269580% (0)68%$85,310
2020179540% (0)56%$46,578
2019136500% (0)74%$39,397
2018151410% (0)77%$46,054
201720344None72%$51,987
2016164480% (0)70%$32,903
201598340% (0)84%$17,042
2014138340% (0)87%$30,116
201319867None80%$40,720

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 3 drugs

Part D drugs prescribed in 2023
Trelegy Ellipta50$40,086$802
Breo Ellipta37$16,133$436
Albuterol Sulfate Hfa23$996$43

2022: 4 drugs

Part D drugs prescribed in 2022
Trelegy Ellipta62$43,093$695
Breo Ellipta17$6,642$391
Arnuity Ellipta12$2,459$205
Albuterol Sulfate Hfa11$506$46

2021: 7 drugs

Part D drugs prescribed in 2021
Trelegy Ellipta51$35,151$689
Breo Ellipta18$8,549$475
Albuterol Sulfate Hfa46$2,587$56
Arnuity Ellipta11$2,113$192
Ventolin Hfa15$1,294$86
Montelukast18$491$27
Pantoprazole16$132$8

2020: 5 drugs

Part D drugs prescribed in 2020
Trelegy Ellipta26$14,738$567
Spiriva11$5,036$458
Arnuity Ellipta11$1,988$181
Albuterol Sulfate Hfa18$1,200$67
Gabapentin14$393$28

2019: 2 drugs

Part D drugs prescribed in 2019
Spiriva15$7,468$498
Breo Ellipta11$5,385$490

2018: 5 drugs

Part D drugs prescribed in 2018
Advair Diskus19$10,476$551
Breo Ellipta15$7,636$509
Proair Hfa19$1,975$104
Ventolin Hfa16$873$55
Montelukast14$470$34

2017: 5 drugs

Part D drugs prescribed in 2017
Breo Ellipta36$15,693$436
Advair Diskus28$13,947$498
Proair Hfa17$2,078$122
Ventolin Hfa25$1,449$58
Montelukast20$342$17

2016: 6 drugs

Part D drugs prescribed in 2016
Breo Ellipta32$9,648$302
Advair Diskus18$6,290$349
Symbicort13$5,360$412
Spiriva14$4,969$355
Ventolin Hfa14$784$56
Montelukast16$208$13

2015: 3 drugs

Part D drugs prescribed in 2015
Advair Diskus14$4,301$307
Ventolin Hfa20$1,160$58
Proair Hfa12$1,027$86

2014: 6 drugs

Part D drugs prescribed in 2014
Advair Diskus27$8,000$296
Spiriva16$4,692$293
Qvar13$3,385$260
Symbicort12$3,086$257
Ventolin Hfa24$1,251$52
Omeprazole11$58$5

2013: 6 drugs

Part D drugs prescribed in 2013
Advair Diskus51$16,709$328
Spiriva28$9,494$339
Qvar23$4,396$191
Symbicort16$3,797$237
Ventolin Hfa13$617$47
Proair Hfa12$569$47

Money from drug and device companies

$122 in 2025

Industry payments by year
202511None$122
202422None$156
202311None$11
202212None$43
202111None$125
201911None$143

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
GenzymeNone$122
1 payment
  • Meals · 2025-07-17 · $122
See the published payment
Every published payment
GenzymeMeals · 2025-07-17None$122
See earlier years (2024, 2023, 2022, 2021, 2019)

2024: $156

Payments by company in 2024
PfizerElrexfio$127
1 payment
  • Meals for Elrexfio · 2024-11-21 · $127
AstraZeneca Pharmaceuticals LPTezspire$29
1 payment
  • Meals for Tezspire · 2024-03-08 · $29

2023: $11

Payments by company in 2023
Merck Sharp & DohmeZerbaxa$11
1 payment
  • Education for Zerbaxa · 2023-07-26 · $11

2022: $43

Payments by company in 2022
Merck Sharp & DohmeZerbaxa$43
2 payments
  • Education for Zerbaxa · 2022-10-17 · $22
  • Education for Zerbaxa · 2022-07-25 · $22

2021: $125

Payments by company in 2021
GenzymeNone$125
1 payment
  • Meals · 2021-10-29 · $125

2019: $143

Payments by company in 2019
InsmedNone$143
1 payment
  • Meals · 2019-09-16 · $143

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Biotest AG · A Randomized, Placebo-Controlled, Double-Blind, Multi-Center, Phase III Trial To Assess the Efficacy and Safety of Trimodulin (Bt588) in Hospitalized Subjects With Severe Community-Acquired Pneumonia (Scap) · 2025Their institution$126,869
United Therapeutics Corporation · A Phase 4, Prospective, Multicenter, Single-Arm Study of A Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy To Reverse Right Ventricular Remodeling in Patients With Pulmonary Arterial Hypertension: Artisan (Afterload Reduction To Improve Right Ventricular Structure and Function) · 2024Their institution$33,848
Merck Sharp & Dohme Corporation · A Phase III, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial Tostudy the Safety, Tolerability, and Efficacy of Imipenem,Cilastatin,Relebactam Mk-7655aversus Piperacillin,Tazobactam in Subjects With Hospital-Acquired Bacterial Pneumonia Orventilator-Associated Bacterial Pneumonia · 2020Their institution$27,143
Bayer Healthcare Pharmaceuticals Inc. · Bay 632521, Riociguat Users Registry the Roar Registry · 2024Their institution$20,281
Janssen Research & Development, LLC · Phase 2 Randomized Double Blind Placebo Controlled Study To Evaluate the Efficacy and Safety of Sirukumab in Confirmed Covid19 Severe Disease · 2021Their institution$17,038
United Therapeutics Corporation · A Phase 4, Prospective, Multicenter, Single-Arm Study of A Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy To Reverse Right Ventricular Remodeling in Patients With Pulmonary Arterial Hypertension: Artisan (Afterload Reduction To Improve Right Ventricular Structure and Function) · 2025Their institution$14,731
Merck Sharp & Dohme Corporation · A Prospective, Randomized, Double-Blind, Multicenter, Phase 3study To Assess the Safety and Efficacy of Intravenousceftolozane,Tazobactam Compared With Meropenem in Adultpatients With Ventilated Nosocomial Pneumonia · 2019Their institution$11,890
Merck Sharp & Dohme LLC · A Prospective, Randomized, Double-Blind, Multicenter, Phase 3 Study To Assess the Safety and Efficacy of Intravenous Ceftolozane,Tazobactam Compared With Meropenem in Adult Patients With Ventilated Nosocomial Pneumonia · 2023Their institution$182

Professional record

NPI
1992840490
Licence
CA A111780California A111780: Current · expires 2027-05-31
Group
Central California Faculty Medical Group Inc · Fresno Community Hospital and Medical Center
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RP1001X (207RP1001X); Internal medicine (207R00000X); Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RS0012X (207RS0012X)
Mailing address
2625 E Divisadero St, Fresno, CA, 93721
NPI first listed
2007-02-21
NPI last updated
2024-09-16
NPI record certified
2024-09-16

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 2335 E Kashian Ln Ste 280, Fresno, CA, 93701